David A. Evans has over 40 years’ experience serving in various executive-level positions in software development, clinical research, regulatory and healthcare industries. He has championed the advancement of scientific information exchange through the continued development and promotion of data and metadata standards, while fostering collaboration with the global community. His expertise extends to information standards, regulatory compliance, and quality governance. Notably, he architected and developed the first electronic drug submission to the US FDA in 1985 and has since overseen more than 100 electronic regulatory submissions and complex clinical data warehouse systems.
Dave has served as the CEO of CDISC, and has held the position of Principal Director, Global Head of Quality Governance and Regulatory Compliance for Accenture Life Science, where he served for eight years. He also served as CIO of Octagon Research Solutions, which was later acquired by Accenture. His deep understanding of industry needs is further evidenced by his previous roles as Chair of the CDISC Advisory Council and member of the CDISC Board of Directors. Dave holds an MS in Biomedical Engineering from Drexel University and a BS in Biology from Ursinus College, grounding his extensive experience in a strong academic foundation.